NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine

CompletedN/A

Sponsor: Sanofi Pasteur, a Sanofi Company

Conditions: Pertussis

Interventions: Tetanus Toxoid, acellular pertussis, diphtheria toxoid

Countries: United States

To further characterize the vaccine safety profile and to identify any signals of potentially vaccine-related adverse events (AEs) not detected during pre-licensure studies.

Eligibility overview

Sex: ALL

Healthy volunteers: Yes

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Receipt of ADACEL vaccine during the study period

Exclusion Criteria:

* None

Locations (3)

Oakland, California, United States
Aurora, Colorado, United States
Portland, Oregon, United States